Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma
dc.contributor.author | Massari, Francesco | |
dc.contributor.author | Ciccarese, Chiara | |
dc.contributor.author | Santoni, Matteo | |
dc.contributor.author | Lopez-Beltran, Antonio | |
dc.contributor.author | Scarpelli, Marina | |
dc.contributor.author | Montironi, Rodolfo | |
dc.contributor.author | Cheng, Liang | |
dc.contributor.department | Department of Pathology and Laboratory Medicine, IU School of Medicine | en_US |
dc.date.accessioned | 2016-05-26T18:30:24Z | |
dc.date.available | 2016-05-26T18:30:24Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Fibroblast growth factor receptor (FGFR) pathway is involved in driving vascular endothelial growth factor (VEGF)-independent tumor angiogenesis, as a compensatory mechanism to escape VEGF-targeted therapies. Therefore, targeting FGF/FGFR axis seems to be a promising strategy in order to inhibit tumor angiogenesis and reduce resistance to VEGF receptor-tyrosine kinase inhibitors. This editorial is focused on the role of FGF/FGFR pathway in renal cell carcinoma and on the ongoing trials of emerging agents targeting this axis. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Massari, F., Ciccarese, C., Santoni, M., Lopez-Beltran, A., Scarpelli, M., Montironi, R., & Cheng, L. (2015). Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma. Expert Review of Anticancer Therapy, 15(12), 1367–1369. http://doi.org/10.1586/14737140.2015.1110488 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/9679 | |
dc.language.iso | en | en_US |
dc.publisher | Taylor and Francis | en_US |
dc.relation.isversionof | 10.1586/14737140.2015.1110488 | en_US |
dc.relation.journal | Expert Review of Anticancer Therapy | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | Author | en_US |
dc.subject | fibroblast growth factor receptor | en_US |
dc.subject | kidney | en_US |
dc.subject | personalized medicine | en_US |
dc.title | Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma | en_US |
dc.type | Article | en_US |